SHILPAMED

Shilpa Medicare LimitedNSE
₹959.9+20.40 (+2.17%)

Market Closed · NSE · INR

Open

₹949.85

High

₹965

Low

₹937.1

Prev Close

₹939.5

52-Week Range99% from low
₹267
₹964.95

Market Cap

₹18.37 K Cr

Mid Cap

P/E (TTM)

61.8

EPS

₹15.2

Div Yield

0.12%

P/B Ratio

7.25

ROE

11.5%

Key Metrics

Forward P/E45.03
Book Value₹132.49
Debt/Equity0.25×
Revenue Growth44.9%
Profit Margin17.67%
Operating Margin28.25%
Volume7.15 L
Avg Volume (20d)16.17 L
Delivery %36.75%
Trades24,063

Analyst Ratings(4 analysts)

Strong Buy

Target Price

₹881

-8.2% upside

Buy4
Low: ₹635Median: ₹845High: ₹1,200

Current price: ₹960

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, su...

vbshilpa.com1,241 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 1.60/share
21
22
25
26
04 Sept 20260.60
17 Sept 20251.00
19 Sept 20221.10
20 Sept 20211.10
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.